The Dr. John G. Bartlett ARLG Fellowship

In addition to shaping ARLG’s early development, John Bartlett, M.D. designed and led the original Mentoring Committee. This fellowship is named in honor of a colleague, mentor, and friend whose legacy includes unparalleled achievements and a commitment to supporting the work of early-career researchers.

ARLG shares John’s dedication to combating the threat of antibacterial resistance by providing mentorship and guidance to the next generation of infectious diseases researchers. The goal of the Dr. John G. Bartlett ARLG Fellowship is to inspire and support work that will continue to advance the science of antibacterial resistance well into the future.

About the Fellowship

The Dr. John G. Bartlett ARLG Fellowship lasts up to two years and is a fully funded, competitive opportunity to acquire expertise in antibacterial resistance clinical research. The ARLG Fellowship is designed for MD Infectious Disease (ID) fellows interested in pursuing research, training, and a subsequent career in the patient-oriented study of antibacterial resistance. Recipients will be integrated into the ARLG mission and programs.

 

The Bartlett ARLG Fellowship program is full and is not accepting applications at this time. We anticipate re-opening in January 2025.

If you have questions about this opportunity, please contact us at ARLG_Network@dm.duke.edu.

 

Recipients of the award will receive:

  1. Salary for up to two years of ID fellowship.
  2. Mentoring in antibacterial resistance research.
  3. Formal training in epidemiology or statistics at the Duke University School of Medicine Clinical Research Training Program, or an equivalent program at another institution. Costs for this epidemiology and statistics coursework will be paid by the ARLG.
  4. Mentoring from senior mentors who are part of the ARLG.
  5. Training in confidentiality, patient safety, and regulatory affairs.
  6. Access to ARLG Virtual Biorepository bacterial strains that can be used to support proposed research.

ARLG is committed to a community of learning where fellows from diverse backgrounds and experiences are supported in their professional and intellectual goals and pursuits. We actively encourage qualified fellows from every background to apply.

Apply Now

“ARLG is not merely a funding mechanism; rather, it is a community of scientists who ardently pursue improved human health through a better understanding of the optimal prevention, detection, and management of antibacterial resistance.”

Judith A. Anesi, MD
University of Pennsylvania Perelman School of Medicine

Hear from other ARLG Fellows

Help us spread the word!

 

How to Become an ARLG Fellow

Eligibility Criteria Expand

  • Applicants who work at a US domestic institution for the duration of the award irrespective of citizenship or visa status are eligible to apply. The clinical research project may be conducted in the US or internationally.
  • MD, Infectious Disease fellow.

Application and Selection Process Expand

Applicants who are interested in the ARLG Fellow position are required to submit the following:

  1. Applicant’s NIH biosketch.
  2. Mentor’s NIH biosketch and letter of support.
  3. Letters of recommendation (two are required).
  4. For applicants who are not US citizens or non-citizen nationals or lawfully admitted for permanent residence, a letter from the applicant’s institution determining and documenting that the candidate’s visa will allow him or her to remain in the US long enough to complete the award.
  5. ARLG Fellowship proposal. Please include the following sections: 1) Candidate’s background, goals, and objective, 2) Candidate’s plan for career development/training activities, and 3) Clinical research plan.

Candidate background, goals and objectives (1-2 pages, 1 Inch Margins; Font – Arial 11 pt; Double-Spaced) Expand

  •  Describe the candidate’s commitment to an academic career studying antibacterial resistance consistent with the ARLG mission and goals.
  •  Provide evidence of the candidate’s potential to develop into an independent investigator in antibacterial resistance.
  •  Describe the candidate’s short term and long term academic goals.

Candidate’s Plan for Career Development/Training Activities during Award Period (1-2 pages, 1 Inch Margins; Font – Arial 11 pt; Double-Spaced) Expand

  • The career development/training activities plan during the award period will depend greatly on the candidate’s background. We expect the plan to vary from application to application.
  • The candidate and the mentor are jointly responsible for the preparation of the career development plan. A timeline is often helpful. The mentor, in consultation with the applicant, may form a mentoring team (or an advisory committee) to assist with the development of the program of study or to monitor the candidate’s progress through the career development program.
  • The didactic (if any) and the research aspects of the plan must be designed to develop the necessary knowledge and research skills in scientific areas relevant to the candidate’s career goals. The candidate must demonstrate they have received training or will participate in courses that will help them achieve their short term and long term academic goals.
  • It is mandatory that applicants include some planned coursework or completed coursework demonstrating proficiency in clinical research in epidemiology and statistics that are part of traditional MS or MPH coursework. This coursework must allow the researcher to be an expert in patient-oriented research in antibacterial resistance. Examples include coursework in clinical trials, cohort design, case-control design. Epidemiology skills, and statistics skills in these areas are required.

Clinical research plan: (3-4 pages, 1 Inch Margins; Font – Arial 11 pt; Double-Spaced) Expand

The clinical research plan should address a U.S. antibacterial resistance problem consistent with the ARLG mission and scope and include the following sections (as applicable): Study Title, Study Rationale, Hypothesis, Objectives and Endpoints, Study Centers (proposed), Study Population, Study Design, Intervention/Treatment Regimens, Sample Size Estimate, Timeline, New and/or Unique Assay/Technology, Limitations, External Support/ Collaboration, References, and Diversity and Inclusion Plan (separate section 250-500 words).